Role of Sirtuins and Calorie Restriction in Neuroprotection: Implications in Alzheimer's and Parkinson's Diseases

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|17|31|3418-3433

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.17, Iss.31, 2011-10, pp. : 3418-3433

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Sirtuins: Possible Clinical Implications in Cardio and Cerebrovascular Diseases

By  

Current Drug Targets, Vol. 18, Iss. 4, 2017-02 ,pp. : 473-484

Bentham Science Publishers

Access to resources Recommend Favorite

Inflammatory Process in Alzheimer’s and Parkinson's Diseases: Central Role of Cytokines

By  

Current Pharmaceutical Design, Vol. 22, Iss. 5, 2016-02 ,pp. : 541-548

Bentham Science Publishers

Access to resources Recommend Favorite

Potential Therapeutic Targets for Neurodegenerative Diseases: Lessons Learned from Calorie Restriction

By  

Current Drug Targets, Vol. 11, Iss. 10, 2010-10 ,pp. : 1281-1292

Bentham Science Publishers

Access to resources Recommend Favorite

Recent Advances on the Role of Neurogenesis in the Adult Brain: Therapeutic Potential in Parkinson's and Alzheimer's Diseases

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 16, Iss. 7, 2017-10 ,pp. : 740-748

Bentham Science Publishers

Access to resources Recommend Favorite

Role of Methylene Blue in Trauma Neuroprotection and Neuropsychiatric Diseases

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 15, Iss. 8, 2016-09 ,pp. : 976-986

Bentham Science Publishers

Access to resources Recommend Favorite